Excitotoxic protection by polyanionic polysaccharide: Evidence of a cell survival pathway involving AMPA receptor-MAPK interactions

Journal of Neuroscience Research

Volumn 85, Issue 2, 2007, Pages 294-302

  Chicoine, Linda M ^a,b   Bahr, Ben A ^b  

^a Cognetix Inc ^*  (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Dextran sulfate; Hippocampal slice cultures; MAP kinase; Neuroprotection; Rat brain

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; DEXTRAN SULFATE; EXCITOTOXIN; GLYCOSAMINOGLYCAN; MITOGEN ACTIVATED PROTEIN KINASE; POLYANION; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; BRAIN FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; EXCITOTOXICITY; EXPERIMENTAL MODEL; HIPPOCAMPUS; IMMUNOBLOTTING; MEMBRANE PERMEABILITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; RAT; SYNAPSE; SYNAPTOGENESIS;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DEXTRAN SULFATE; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY AMINO ACIDS; HIPPOCAMPUS; IMMUNOBLOTTING; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; ORGAN CULTURE TECHNIQUES; POLYMERS; POLYSACCHARIDES; RATS; RECEPTORS, AMPA;

EID: 33846886096     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21117     Document Type: Article

References (64)

1. Apati A, Janossy J, Brozik A, Bauer PO, Magocsi, M. 2003. Calcium induces cell survival and proliferation through the activation of the MAPK pathway in a human hormone-dependent leukemia cell line, TF-1. J Biol Chem 278:9235-9243.
2. Arai AC, Xia YF, Rogers G, Lynch G, Kessler M. 2002. Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action. J Pharmacol Exp Ther 303:1075-1085.
3. Bahr BA. 2000. Integrin-type signaling has a distinct influence on NMDA-induced cytoskeletal disassembly. J Neuroscience Res 59:827-832.
4. Bahr BA, Tiriveedhi S, Park GY, Lynch G. 1995. Induction of calpain-mediated spectrin fragments by pathogenic treatments in long-term hippocampal slices. J Pharmacol Exp Ther 273:902-908.
5. R antigen (GR53) in brain tissue. Neuroscience 74:707-721.
6. Bahr BA, Solomon Y, Suppiramaniam V. 1999. Structural chemistries underlying synaptic signaling and regulation. J Mol Biol Biotechnol 1:35-48.
7. Bahr BA, Bendiske J, Brown QB, Munirathinam S, Caba E, Rudin M, Urwyler S, Sauter A, Rogers G. 2002. Survival signaling and selective neuroprotection through glutamatergic transmission. Exp Neurol 174:37-47.
8. Bambrick LL, Yarowsky PJ, Krueger BK. 1995. Glutamate as a hippocampal neuron survival factor: an inherited defect in the trisomy 16 mouse. Proc Natl Acad Sci U S A 92:9692-9696.
9. Brückner G, Brauer K, Härtig W, Wolff JR, Rickmann MJ, Derouiche A, Delpech B, Girard N, Oertel WH, Reichenbach A. 1993. Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain. Glia 8:183-200.
10. Brückner G, Szeoke S, Pavlica S, Grosche J, Kacza J. 2006. Axon initial segment ensheathed by extracellular matrix in perineuronal nets. Neuroscience 138:365-375.
11. Caba E, Bahr BA. 2004. Biphasic activation of NF-κB in the excitotoxic hippocampus. Acta Neuropathol 108:173-182.
12. Caba E, Brown QB, Kawasaki B, Bahr BA. 2002. Peptidyl α-keto amide inhibitor of calpain blocks excitotoxic damage without affecting signal transduction events. J Neurosci Res 67:787-794.
13. Carlson SS, Hockfield S. 1996. Central nervous system. In: Comper WD, editor. Extracellular matrix vol 1: tissue function. Amsterdam: Harwood Academic Publishers. p 1-23.
14. Celio MR, Spreafico R, De Biasi S, Vitellaro-Zuccarello L. 1998. Perineuronal nets: past and present. Trends Neurosci 21:510-515.
15. Chicoine LM, Suppiramaniam V, Vaithianathan T, Gianutsos G, Bahr BA. 2004. Sulfate- and size-dependent polysaccharide modulation of AMPA receptor properties. J Neurosci Res 75:408-416.
16. Dicou E, Rangon C, Guimiot F, Spedding M, Gressens P. 2003. Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mice brain. Brain Res 970:221-225.
17. 2+ concentration. Philos Trans R Soc Lond B Biol Sci 345:251-256.
18. Hall RA, Vodyanoy V, Quan A, Sinnarajah S, Suppiramaniam V, Kessler M, Bahr BA. 1996. Effects of heparin on the properties of solubilized and reconstituted rat brain AMPA receptors. Neurosci Lett 217:179-183.
19. Hayashi T, Umemori H, Mishina M, Yamamoto T. 1999. The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn. Nature 397:2-76.
20. Hockfield S, Kalb RG, Zaremba S, Fryer H. 1990. Expression of neural proteoglycans correlates with the acquisition of mature neuronal properties in the mammalian brain. Cold Spring Harbor Symp Quant Biol 55:505-514.
21. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252:851-853.
22. Hongpaisan J, Winters CA, Andrews SB. 2004. Strong calcium entry activates mitochondrial superoxide generation, upregulating kinase signaling in hippocampal neurons. J Neurosci 24:10878-10887.
23. Karanian DA, Brown QB, Makriyannis A, Bahr BA. 2005a. Blocking cannabinoid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampus. Eur J Pharmacol 508:47-56.
24. Karanian DA, Brown QB, Makriyannis A, Kosten TA, Bahr BA. 2005b. Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity. J Neurosci 25:7813-7820.
25. Kumar SS, Bacci A, Kharazaia V, Huguenard JR. 2002. A developmental switch of AMPA receptor subunits in neocortical pyramidal neurons. J Neurosci 22:3005-3015.
26. Lander C, Zhang H, Hockfield S. 1998. Neurons produce a neuronal cell surface-associated chondroitin sulfate proteoglycan. J Neurosci 18:174-183.
27. Lauri SE, Kaukinen S, Kinnunen T, Ylinen A, Imai S, Kaila K, Taira T, Rauvala H. 1999. Regulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. J Neurosci 19:1226-1235.
28. Lee KS, Frank S, Vanderklish P, Arai A, Lynch G. 1991. Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc Natl Acad Sci U S A 88:7233-7237.
29. Lilienbaum A, Israël A. 2003. From calcium to NF-κB signaling pathways in neurons. Mol Cell Biol 23:2680-2698.
30. Limatola C. 2004. Neurotrophic effects of AMPA. Cerebellum 3:2-10.
31. Limatola C, Ciotti MT, Mercanti D, Vacca F, Ragozzino D, Giovannelli A, Santoni A, Eusebi F, Miledi R. 2000. The chemokine growth-related gene product β protects rat cerebellar granule cells from apoptotic cell death through α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. Proc Natl Acad Sci U S A 97:6197-6201.
32. Limatola C, Ciotti MT, Mercanti D, Santonit A, Eusebi F. 2002. Signaling pathways activated by chemokine receptor CXCR2 and AMPA-type glutamate receptors and involvement in granule cells survival. J Neuroimmunol 123:9-17.
33. McCracken E, Hunter AJ, Patel S, Graham DI, Dewar D. 1999. Calpain activation and cytoskeletal protein breakdown in the corpus callosum of head-injured patients. J Neurotrauma 9:749-761.
34. McKinney RA, Capogna M, Durr R, Gahwiler BH. 1999. Miniature synaptic events maintain dendritic spines via AMPA receptor activation. Nat Neurosci 2:44-49.
35. 2+ influx, synaptic signaling, and survival. J Neurosci 23:1825-1831.
36. Muller D, Wang C, Skibo G, Toni N, Cremer H, Calaora V, Rougon G, Kiss JZ. 1996. PSA-NCAM is required for activity-induced synaptic plasticity. Neuron 17:413-422.
37. Munirathinam S, Rogers G, Bahr BA. 2002. Positive modulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors elicits neuroprotection after trimethyltin exposure in hippocampus. Toxicol Appl Pharmacol 185:111-118.
38. Neumar RW, Meng FH, Mills AM, Xu YA, Zhang C, Welsh FA, Siman R. 2001. Calpain activity in the rat brain after transient forebrain ischemia. Exp Neurol 170:27-35.
39. Nichol KA, Everett AW, Schulz M, Bennett MR. 1994. Retinal ganglion cell survival in vitro maintained by a chondroitin sulfate proteoglycan from the superior colliculus carrying the HNK-1 epitope. J Neurosci Res 37:623-632.
40. Nichol KA, Schulz MW, Bennett MR. 1995. Nitric oxide-mediated death of cultured neonatal retinal ganglion cells: neuroprotective properties of glutamate and chondroitin sulfate proteoglycan. Brain Res 697:1-16.
41. 2+-permeable AMPA/ kainate channel expression in hippocampal pyramidal neurons: fluorescence imaging and immunocytochemical assessment. J Neurosci 23:10521-10530.
42. Okamoto M, Mori S, Ichimura M, Endo H. 1994. Chondroitin sulfate proteoglycans protect cultured rat's cortical and hippocampal neurons from delayed cell death induced by excitatory amino acids. Neurosci Lett 172:51-54.
43. O'Neill MJ, Bleakman D, Zimmerman DM, Nisenbaum ES. 2004. AMPA receptor potentiators for the treatment of CNS disorders. CNS Neurol Disord Drug Targets 3:181-194.
44. Passafaro M, Nakagawa T, Sala C, Sheng M. 2003. Induction of dendritic spines by an extracellular domain of AMPA receptor subunit GluR2. Nature 424:677-681.
45. 2+-permeable AMPA receptors induce phosphorylation of cAMP response element-binding protein through a phosphatidylinositol 3-kinase-dependent stimulation of the mitogen-activated protein kinase signaling cascade in neurons. J Neurosci 19:5861-5874.
46. Priel A, Kolleker A, Ayalon G, Gillor M, Osten P, Stern-Bach Y. 2005. Stargazin reduces desensitization and slows deactivation of the AMPA-type glutamate receptors. J Neurosci 25:2682-2686.
47. + concentrations. J Neurochem 58:649-658.
48. Roberts-Lewis JM, Savage MJ, Marcy VR, Pinsker LR, Siman R. 1994. Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J Neurosci 14:3934-3944.
49. Rolls A, Avidan H, Cahalon L, Schori H, Bakalash S, Litvak V, Lev S, Lider O, Schwartz M. 2004. A disaccharide derived from chondroitin sulfate proteoglycan promotes central nervous system repair in rats and mice. Eur J Neurosci 20:1973-1983.
50. Saido TC, Yokota M, Nagao S, Yamaura I, Tani E, Tsuchiya T, Suzuki K, Kawashima S. 1993. Spatial resolution of fodrin proteolysis in postischemic brain. J Biol Chem 268:25239-25243.
51. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM. 1999. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19:2455-2463.
52. Sinnarajah S, Suppiramaniam V, Kumar KP, Hall RA, Bahr BA, Vodyanoy V. 1999. Heparin modulates the single channel kinetics of reconstituted AMPA receptors from rat brain. Synapse 31:203-209.
53. Suppiramaniam V, Bahr BA, Sinnarajah S, Owens K, Rogers G, Yilma S, Vodyanoy V. 2001. Member of the ampakine class of memory enhancers prolongs the single channel open time of reconstituted AMPA receptors. Synapse 40:154-158.
54. Suppiramaniam V, Vaithianathan T, Manivannan K, Muralikrishnan D, Parameshwaran K, Bahr BA. 2006. Modulatory effects of dextran sulfate and fucoidan on binding and channel properties of AMPA receptors isolated from rat brain. Synapse 60:456-464.
55. Vaithianathan T, Matthias K, Bahr B, Schachner M, Suppiramaniam V, Dityatev A, Steinhäuser C. 2004. Neural cell adhesion molecule-associated polysialic acid potentiates α-amino-3-hydroxy-5-methylisoxazole-4- propionic acid receptor currents. J Biol Chem 279:47975-47984.
56. Vanderklish PW, Bahr BA. 2000. The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. J Exp Pathol 81:323-339.
57. Vutskits L, Djebbara-Hannas Z, Zhang H, Paccaud JP, Durbec P, Rougon G, Muller D, Kiss JZ. 2001. PSA-NCAM modulates BDNF-dependent survival and differentiation of cortical neurons. Eur J Neurosci 7:1391-1402.
58. Walzer M, Lorens S, Hejna M, Fareed J, Hanin I, Cornelli U, Lee JM. 2002. Low molecular weight glycosaminoglycan blockade of β-amyloid induced neuropathology. Eur J Pharmacol 445:211-220.
59. Wang Y, Durkin JP. 1995. α-Amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid, but not N-methyl-D-aspartate, activates mitogen-activated protein kinase through G-protein βγ subunits in rat cortical neurons. J Biol Chem 270:22783-22787.
60. i-protein in cortical neurons. Nature 389:502-504.
61. Wenthold RJ, Petralia RS, Blahos J II, Niedzielski AS. 1996. Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci 16:1982-1989.
62. Wu X, Zhu D, Jian X, Okagaki P, Mearow K, Zhu G, McCall S, Banaudha K, Lipsky RH, Marini AM. 2004. AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-related kinase to upregulate BDNF gene expression. J Neurochem 90:807-818.
63. 2+-permeable AMPA/kainate channels in hippocampal pyramidal neurons. J Comp Neurol 409:250-260.
64. Zhu C, Wang X, Xu F, Bahr BA, Shibata M, Uchiyama Y, Hagberg H, Blomgren K. 2005. The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ 12:162-176.